Effect of calcitonin gene-related peptide on glucose and gastric inhibitory polypeptide-stimulated insulin release from cultured newborn and adult rat islet cells.
Calcitonin gene-related peptide (CGRP) is a 37-amino acid peptide that is present in peripheral cells of islets and in nerves around and within islets. CGRP can inhibit insulin secretion in vitro and in vivo. Whether the inhibitory action of CGRP is mediated by somatostatin or by nerve terminals is, however, not known. The objective of this study was to examine the effect of CGRP on insulin secretion, using cultured newborn and adult rat islet cells which did not contain nerve terminals. In adult rat islet cells, CGRP (10(-10) to 10(-8) M) significantly inhibited glucose-stimulated and gastric inhibitory polypeptide (GIP)-potentiated insulin secretion, but in newborn rat islet cells, CGRP did not inhibit glucose-stimulated insulin secretion. Inhibition of glucose-stimulated and GIP-potentiated insulin release was dependent on the glucose concentration during the prestimulation period. CGRP did not stimulate release of somatostatin. These findings suggest that rat CGRP can act directly on beta-cells through a specific receptor that is absent in newborn rat beta-cells.
Ishizuka
J
J
Department of Surgery, University of Texas Medical Branch, Galveston 77550.
Greeley
G H
GH
Cooper
C W
CW
Thompson
J C
JC
D000375:Aging; D000818:Animals; D000831:Animals, Newborn; D015740:Calcitonin Gene-Related Peptide; D002478:Cells, Cultured; D005749:Gastric Inhibitory Polypeptide / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D007700:Kinetics; D009479:Neuropeptides / Q000494:pharmacology*; D051381:Rats; D011916:Rats, Inbred F344
D007328:Insulin; D009479:Neuropeptides; D005749:Gastric Inhibitory Polypeptide; D005947:Glucose; D015740:Calcitonin Gene-Related Peptide